Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor

Gynecologic Oncology

Volumn 97, Issue 2, 2005, Pages 559-567

  Jin, Hyun Sun ^a   Park, Eun Kyung ^b   Lee, Joon Mo ^b   Namkoong, Sung Eun ^b   Kim, Do Gang ^b   Lee, Young Joo ^c   Jun, Heung Jae ^a   Han, Byoung Don ^d   Bae, Su Mi ^a   Ahn, Woong Shick ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sejong University   (South Korea)

^d Korea Telecom Research Cent   (South Korea)

Author keywords

Adenovirus; Cervical cancer; HPV 16 E7; IL 12

Indexed keywords

ADENOVIRUS VECTOR; CANCER ANTIBODY; GAMMA INTERFERON; PROTEIN E7; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LEUKOCYTE COUNT; LEUKOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TUMOR; TUMOR VOLUME;

EID: 20944440631     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.01.046     Document Type: Article

References (32)

1. M.K. Gately, B.B. Desai, A.G. Wolitzky, P.M. Quinn, C.M. Dwyer, and F.J. Podlaski Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) J. Immunol. 147 1991 874 882
2. U. Gubler, A.O. Chua, D.S. Schoenhaut, C.M. Dwyer, W. McComas, and R. Motyka Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor Proc. Natl. Acad. Sci. 88 1991 4143 4147
3. G. Trinchieri, and P. Scott Interleukin-12: a proinflammatory cytokine with immunoregulatory functions Res. Immunol. 146 1995 423 431
4. C. Yoon, S.C. Johnston, J. Tang, M. Stahl, J.F. Tobin, and W.S. Somers Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12 EMBO J. 19 2000 3530 3541
5. K. Vandenbroeck, I. Alloza, M. Gadina, and P. Matthys Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges J. Pharm. Pharmacol. 56 2004 145 160
6. R. Manetti, P. Parronchi, M.G. Giudizi, M.P. Piccinni, E. Maggi, and G. Trinchieri Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells J. Exp. Med. 177 1993 1199 1204
7. W.M. Siders, P.W. Wright, J.A. Hixon, W.G. Alvord, T.C. Back, and R.H. Wiltrout T cell and NK cell- independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus J. Immunol. 160 1998 5465 5474
8. H. Tahara, H.J. Zeh III, W.J. Storkus, I. Pappo, S.C. Watkins, and U. Gubler Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor growth and induce anti-tumor immunity to a murine melanoma in vivo Cancer Res. 54 1994 182 189
9. J.N. Parker, G.Y. Gillespie, C.E. Love, S. Randall, R.J. Whitley, and J.M. Markert From the cover: engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors Proc. Natl. Acad. Sci. 97 2000 2208 2213
10. I. Puisieux, L. Odin, D. Poujol, P. Moingeon, J. Tartaglia, and W. Cox Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity Hum. Gene Ther. 9 1998 2481 2492
11. D. Paul, M.H. Qazilbash, K. Song, H. Xu, B.K. Sinha, and J. Liu Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12) Cancer Gene Ther. 7 2000 308 315
12. A.L. Rakhmilevich, K. Janssen, J. Turner, J. Culp, and N.S. Yang Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12 Hum. Gene Ther. 8 1997 1303 1311
13. D.W. Liu, Y.P. Tsao, J.T. Kung, Y.A. Ding, H.K. Sytwu, and X. Xiao Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer J. Virol. 74 2000 2888 2894
14. L.K. Borysiewicz, A. Fiander, M. Nimako, S. Man, G.W. Wilkinson, and D. Westmoreland A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer Lancet 347 1996 1523 1527
15. M.E. Boursnell, E. Rutherford, J.K. Hickling, E.A. Rollinson, A.J. Munro, and N. Rolley Construction and characterization of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer Vaccine 14 1996 1485 1494
16. W.S. Ahn, S.M. Bae, T.Y. Kim, T.G. Kim, J.M. Lee, and S.E. Namkoong A therapy modality using recombinant IL-12 adenovirus plus E7 protein in a human papillomavirus 16 E6/E7-associated cervical cancer animal model Hum. Gene Ther. 14 2003 1389 1399
17. T.Y. Kim, H.J. Myoung, J.H. Kim, I.S. Moon, T.G. Kim, and W.S. Ahn Both E7 and CpG-oligodeoxynucleotide are required for protective immunity against challenge with human papillomavirus 16 (E6/E7) immortalized tumor cells: involvement of CD4+ and CD8+ T cells in protection Cancer Res. 62 2002 7234 7240
18. M.F. Mitchell, K. Hamada, K.J. Sastry, A. Sarkar, G. Tortoler-Luna, and J.T. Wharton Transgene expression in the rhesus cervix mediated by an adenovirus expressing beta-galactosidase Am. J. Obstet. Gynecol. 174 1996 1094 1101
19. K.Y. Lin, F.G. Guarnieri, K.F. Staveley-O'Carroll, H.I. Levitsky, J.T. August, and D.M. Pardoll Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Res. 56 1996 21 26
20. A. Gambotto, T. Tuting, D.L. Mcvey, I. Kovesdi, H. Tahara, and M.T. Lotze Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12 Cancer Gene Ther. 6 1999 45 53
21. G.J. Fernando, B. Murray, J. Zhou, and I. Frazer Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16 Clin. Exp. Immunol. 115 1999 397 403
22. C.F. Hung, W.F. Cheng, K.F. Hsu, C.Y. Chai, L. He, and M. Ling Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Cancer Res. 61 2001 3698 3703
23. B.W. Tillman, T.L. Hayes, T.D. DeGruijl, J.T. Douglas, and D.T. Curiel Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model Cancer Res. 60 2000 5456 5463
24. Z. He, A.P. Wlazlo, D.W. Kowalczyk, J. Cheng, Z.Q. Xiang, and W. Giles-Davis Viral recombinant vaccines to the E6 and E7 antigens of HPV-16 Virology 270 2000 146 161
25. A.P. Wlazlo, H. Deng, W. Giles-Davis, and H.C. Ertl DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins Cancer Gene Ther. 11 2004 457 464
26. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-gamma Annu. Rev. Immunol. 15 1997 749 795
27. Z.Q. Xiang, Y. Yang, J.M. Wilson, and H.C.J. Ertl A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier Virology 219 1996 220 227
28. D.M. Da Silva, G.L. Eiben, S.C. Fausch, M.T. Wakabayashi, M.P. Rudolf, and M.P. Velders Cervical cancer vaccines: emerging concepts and developments J. Cell. Physiol. 186 2001 169 182
29. R.E.M. Toes, R.J.J. Blom, R. Offringa, W.M. Kast, and C.J.M. Melief Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors J. Immunol. 156 1996 3911 3918
30. R.E.M. Toes, R. Offringa, R.J.J. Blom, C.J.M. Melief, and W.M. Kast Peptide vaccination can lead to enhance tumor growth through specific T-cell tolerance induction Proc. Natl. Acad. Sci. U. S. A. 93 1996 7855 7860
31. P.W. Chen, M. Wang, V. Bronte, Y. Zhai, S.A. Rosenberg, and N.P. Restifo Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen J. Immunol. 156 1996 224 231
32. Y. Zhai, J.C. Yang, Y. Kawakami, P. Spiess, S.C. Wadsworth, and L.M. Cardoza Antigen-specific tumor vaccines. Development and characterization of recombinant adeno-viruses encoding MART1 or gp100 for cancer therapy J. Immunol. 156 1996 700 710